{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:08:49Z","timestamp":1786118929296,"version":"build-2736575974"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1097\/iae.0b013e31815e98a5","type":"journal-article","created":{"date-parts":[[2008,4,7]],"date-time":"2008-04-07T03:10:24Z","timestamp":1207537824000},"page":"595-605","source":"Crossref","is-referenced-by-count":26,"title":["Safety of Intravitreal Ketorolac and Diclofenac"],"prefix":"10.1097","volume":"28","author":[{"given":"STEPHEN J.","family":"KIM","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NEAL A.","family":"ADAMS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HASSANAIN S.","family":"TOMA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MARIE-LYNE","family":"BELAIR","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JENNIFER E.","family":"THORNE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W RICHARD","family":"GREEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DOUGLAS A.","family":"JABS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210130","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1046\/j.1365-2249.2000.01316.x","article-title":"Triamcinolone acetonide modulates permeability and intercellular adhesion molecure-1 (ICAN-1) expression of the ECV304 cell line: implications for macular degeneration.","volume":"121","author":"Penfold","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"R2-10-20210130","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1001\/jama.296.3.301","article-title":"Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration.","volume":"296","author":"Despriet","year":"2006","journal-title":"JAMA"},{"key":"R3-10-20210130","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1096\/fj.01-0707fje","article-title":"Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-\u03b1 suppression.","volume":"16","author":"Joussen","year":"2002","journal-title":"FASEB J"},{"key":"R4-10-20210130","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.2174\/1381612043383142","article-title":"Vasoactive factors and diabetic retinopathy: vascular endothelial growth factor, cycoloxygenase-2 and nitric oxide.","volume":"10","author":"Wilkinson-Berka","year":"2004","journal-title":"Curr Pharmaceut Design"},{"key":"R5-10-20210130","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ophtha.2003.05.037","article-title":"Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial.","volume":"111","author":"Massin","year":"2004","journal-title":"Ophthalmology"},{"key":"R6-10-20210130","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/archopht.121.1.57","article-title":"Intravitreal injection of triamcinolone for diffuse diabetic macular edema.","volume":"121","author":"Jonas","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"R7-10-20210130","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/S0161-6420(02)00975-2","article-title":"Intravitreal triamcinolone for refractory diabetic macular edema.","volume":"109","author":"Martidis","year":"2002","journal-title":"Ophthalmology"},{"key":"R8-10-20210130","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/00006982-200003000-00004","article-title":"Intravitreal triamcinolone acetonide in exudative age-related macular degeneration.","volume":"20","author":"Danis","year":"2000","journal-title":"Retina"},{"key":"R9-10-20210130","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.ophtha.2006.02.065","article-title":"Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial.","volume":"113","author":"Gillies","year":"2006","journal-title":"Ophthalmology"},{"key":"R10-10-20210130","first-page":"615","article-title":"Statin and aspirin therapy are associated with decreased rates of choroidal neovascularization among patients with age-related macular degeneration.","volume":"137","author":"Wilson","year":"2004","journal-title":"Am J Opthalmol"},{"key":"R11-10-20210130","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.ophtha.2004.10.042","article-title":"Intraocular pressure elevation after intravitreal triamcinolone acetonide injection.","volume":"112","author":"Jonas","year":"2005","journal-title":"Ophthalmology"},{"key":"R12-10-20210130","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ophtha.2004.07.017","article-title":"Intravitreal triamcinolone-induced elevated intraocular pressure is associated with the development of posterior subcapsular cataract.","volume":"112","author":"Gillies","year":"2005","journal-title":"Ophthalmology"},{"key":"R13-10-20210130","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s004170050353","article-title":"Inhibition of diclofenac formulated in hyaluronan on angiogenesis in vitro and its intraocular tolerance in the rabbit eye.","volume":"238","author":"Shen","year":"2000","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R14-10-20210130","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2174\/1568010053622975","article-title":"Inhibition of angiogenesis by non-steroidal anti-inflammatory drugs: from the bench to the bedside and back.","volume":"4","author":"Monnier","year":"2005","journal-title":"Curr Drug Targets Inflamm Allergy"},{"key":"R15-10-20210130","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1001\/archopht.1995.01100060051031","article-title":"A comparison of topical diclofenac with prednisolone for postcataract inflammation.","volume":"113","author":"Roberts","year":"1995","journal-title":"Arch Ophthalmol"},{"key":"R16-10-20210130","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1016\/S0161-6420(00)00365-1","article-title":"Ketorolac versus prednisolone versus combination therapy in the treatment of acute pseudophakic cystoid macular edema.","volume":"107","author":"Heier","year":"2000","journal-title":"Ophthalmology"},{"key":"R17-10-20210130","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1167\/iovs.02-0346","article-title":"Topical nepafenac inhibits ocular neovascularization.","volume":"44","author":"Takahashi","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R18-10-20210130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00004397-200201000-00003","article-title":"Topical nonsteroidal antiinflammatory drugs in ophthalmology.","volume":"42","author":"Flach","year":"2002","journal-title":"Int Ophthalmol Clinics"},{"key":"R19-10-20210130","first-page":"1","article-title":"Duane\u2019s foundations of clinical ophthalmology.","author":"Flach","year":"1994"},{"key":"R20-10-20210130","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0039-6257(92)90095-B","article-title":"Cyclo-oxygenase inhibitors in ophthalmology.","volume":"36","author":"Flach","year":"1992","journal-title":"Surv Ophthalmol"},{"key":"R21-10-20210130","first-page":"613","article-title":"Intraocular penetration of periocular ketorolac and efficacy in experimental uveitis.","volume":"37","author":"Rabiah","year":"1996","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R22-10-20210130","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1001\/archopht.1991.01080020090051","article-title":"The lens opacities case-control study. Risk factors for cataract.","volume":"109","author":"Leske","year":"1991","journal-title":"Arch Ophthalmol"},{"key":"R23-10-20210130","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/S0161-6420(01)00626-1","article-title":"Risk factors associated with age-related nuclear and cortical cataract: a case-control study in the Age-Related Eye Disease Study. Age-Related Eye Disease Study Report Number 5. The Age-Related Eye Disease Study Research Group.","volume":"108","year":"2001","journal-title":"Ophthalmology"},{"key":"R24-10-20210130","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.exer.2005.03.020","article-title":"The influence of diclofenac ophthalmic solution on the intraocular pressure-lowering effect of topical 0.5% timolol and 0.005% latanoprost in primary open-angle glaucoma patients.","volume":"81","author":"Costagliola","year":"2005","journal-title":"Exp Eye Res"},{"key":"R25-10-20210130","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1001\/archopht.123.11.1563","article-title":"Electroretinographic effects of an intravitreal injection of triamcinolone in rabbit retina.","volume":"123","author":"Dierks","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"R26-10-20210130","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1212\/WNL.55.3.347","article-title":"Separating the retinal electrophysiological effects of vigabatrin.","volume":"55","author":"Harding","year":"2000","journal-title":"Neurology"},{"key":"R27-10-20210130","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1167\/iovs.05-0764","article-title":"The safety of intraocular ketorolac in rabbits.","volume":"47","author":"Margalit","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R28-10-20210130","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1001\/archopht.122.11.1687","article-title":"Intravitreal voriconazole: an electroretinographic and histopathologic study.","volume":"122","author":"Gao","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"R29-10-20210130","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1097\/00006982-200410000-00015","article-title":"Retinal function after subconjunctival injection of carboplatin in fibrin sealant.","volume":"24","author":"Pardue","year":"2004","journal-title":"Retina"},{"key":"R30-10-20210130","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00006982-200603000-00001","article-title":"Testing intravitreal toxicity of bevacizumab (avastin).","volume":"26","author":"Manzano","year":"2006","journal-title":"Retina"},{"key":"R31-10-20210130","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/0005-2760(87)90078-6","article-title":"An alternate mechanism for regulation of leukotriene production in leukocytes: studies with an anti-inflammatory drug, sodium diclofenac.","volume":"921","author":"Kothari","year":"1987","journal-title":"Biochem Biophys Acta"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006982-200804000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:57:38Z","timestamp":1786035458000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006982-200804000-00010"}},"subtitle":["An Electroretinographic and Histopathologic Study"],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0b013e31815e98a5","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}